BioSpace News Archive

A new study in the journal PLOS ONE entitled “A quasi-experimental study on stethoscopes contamination with multidrug-resistant bacteria: Its role as a vehicle of transmission” found low levels of stethoscope hygiene education and practice among clinicians and no significant reduction in levels of stethoscope contamination, including nosocomial pathogens and multidrug-resistant (MDR) bacteria

InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV) will release its 2021 third quarter financial results on Monday, May 10, 2021, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. Conference Call Details

Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the Company will participate in the upcoming Truist Securities Life Sciences Summit. Date: Wednesday, May 5, 2021

Zymergen Inc. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced the closing of its initial public offering of 18,549,500 shares of its common stock, including the full exercise by the underwriters of their option to purchase 2,419,500 additional shares of common stock, at a public offering price of $31.00 per share.

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data from the DARE-BVFREE Phase 3 study of DARE-BV1, a thermosetting vaginal gel for the treatment of bacterial vaginosis, will be presented at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting. The meeting will be conducted virtually from April 30 - May 2, 2021.

CARISMA Therapeutics Inc. , a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced it has established a multi-year scientific collaboration with Bruce Blazar , MD, Regents Professor of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapy

Ms. Wildman brings extensive experience in brand building and marketing in the consumer health & wellness space, both at established market leaders and digitally native startups

Experience with BioTrace Medical’s Tempo Temporary Pacing Lead in Mitral Valve Surgeries Presented at Society of Cardiovascular Anesthesiologists’ 43 rd Annual Meeting

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced its abstract featuring data from PROTECT, a pivotal Phase 3 immunogenicity and safety study evaluating the Company’s 3-antigen prophylactic hepatitis B (HBV) vaccine candidate, has been accepted for oral presentation at the National Foundation for Infectious Diseases

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today publishes the 2020 Annual Report.